Attached files
Exhibit 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002
In
connection with the Quarterly Report on Form 10-Q of Edesa Biotech,
Inc. (the “Company”) for the quarter ended December 31, 2019, as filed with the
Securities and Exchange Commission on the date hereof (the
“Report”), I, Kathi Niffenegger, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
|
1.
|
The
Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|
|
2.
|
The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Date:
February 13, 2020
|
By:
|
/s/
Kathi Niffenegger
|
|
|
Kathi
Niffenegger
|
|
|
Chief
Financial Officer
|
|
|
(Principal
Financial Officer)
|